
|
AIDS 2008 Research
Delve into David Wohl, M.D.'s expert analyses of the treatment and complications research that was presented at the XVII International AIDS Conference (AIDS 2008), which took place in Mexico City, Mexico, from August 3-8, 2008. Each activity is available in written or audio formats, and an accompanying slide set is included.
Antiretroviral Strategy Update: Highlights From the XVII International AIDS Conference (1.0 hr.) -- credit available through August 13, 2009
Dr. Wohl identifies the key treatment research from AIDS 2008 relevant to the management of people living with HIV infection in today's clinical practice. From the potency and safety of abacavir [Ziagen] to the efficacy data for raltegravir [Isentress], efavirenz [Sustiva, Stocrin], and TMC278 [rilpivirine], and to the interim results from the GRACE study, Dr. Wohl brings you up to date.
New Insights on HIV/HAART Complications & Coinfections: Highlights From the XVII International AIDS Conference
(0.75 hr.) -- credit available through August 13, 2009
Treating coinfections and the complications of HIV and HIV therapy is a key component to managing the overall health of people living with HIV. In this in-depth research review, Dr. Wohl discusses our evolving understanding of: inflammation and its role in some of the adverse events that plague people with HIV; visceral adiposity; pregabalin [Lyrica] as a treatment for peripheral neuropathy; and viral hepatitis.
|